查看購物車
  • Simplified Chinese
  • English
2021-2031 年亞太地區輸液設備市場報告（範圍、細分、動態和競爭分析）
市場調查報告書
商品編碼
1843392

2021-2031 年亞太地區輸液設備市場報告（範圍、細分、動態和競爭分析）

Asia Pacific Infusion Devices Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 192 Pages | 訂單完成後即時交付

價格

亞太輸液設備市場預計將大幅成長，到 2031 年將達到約 54.9048 億美元，高於 2023 年的 30.142 億美元，在 2023 年至 2031 年的預測期內，年複合成長率(CAGR) 為 7.8%。

執行摘要和市場分析

亞太地區（包括中國、日本、印度、澳洲、韓國等國家）的輸液設備市場正在快速成長。這一成長受到多種因素的推動，包括越來越多的市場參與者推出創新且經濟高效的產品、地方政府的支持舉措，以及癌症和糖尿病等慢性病發病率的上升。本地製造商的存在也提高了該地區輸液設備的可近性。

市場區隔

亞太輸液設備市場可根據產品類型、應用和最終用戶進行細分。

1. 產品類型：市場分為輸液幫浦和輸液器。 2023年，輸液幫浦佔據了市場佔有率的主導地位。輸液泵的細分市場包括容積泵、注射泵、胰島素泵、患者自控鎮痛 (PCA) 泵、腸內泵、植入式泵和彈性泵，其中容積泵佔最大佔有率。輸液器分為排氣式和非排氣式，其中排氣式輸液器市佔率最高。

2. 應用：市場根據應用進一步細分為糖尿病、腫瘤學、疼痛管理、血液學、兒科、胃腸病學等。糖尿病應用在2023年佔據了最大的市場。

3. 最終用戶：輸液設備的最終用戶包括醫院和專科診所、家庭護理機構、門診手術中心等，其中醫院和專科診所將在 2023 年佔據最大的佔有率。

市場展望

亞太輸液設備市場的主要參與者正專注於產品發布、併購和合作等策略性舉措，以增強其針對糖尿病、癌症和慢性疼痛等慢性疾病的產品服務。近期進展包括：

  • 2023 年 2 月，邁瑞推出了 BeneFusion i 系列和 u 系列輸液系統，旨在在各種臨床環境中實現高精度和安全的藥物輸送。
  • 2022 年 3 月，費森尤斯卡比 (Fresenius Kabi) 的 Agilia Connect 輸液系統獲得 FDA 批准，該系統包括配備 Vigilant Software Suite 技術的先進容量泵和注射泵。
  • Eitan Medical 於 2021 年 1 月在英國開展業務，以更好地支援其 Sapphire 輸液幫浦客戶，包括 NHS Trusts 和私人醫療保健提供者。

這些進步顯示產品核准和策略夥伴關係呈現成長趨勢，預計將為輸液設備市場創造重大機會。

國家洞察

亞太輸液設備市場受各國具體動態的影響顯著。中國在2023年成為最大的市場。例如，2021年10月，EOFlow有限公司與長沙三諾生物科技有限公司成立合資企業，以進軍不斷擴大的中國糖尿病市場，專注於生產和分銷穿戴式胰島素幫浦EOPatch。此外，中國在2023年進口了超過200萬台輸液泵，價值23.5萬美元，位居全球第二大輸液泵進口國。需要輸液治療的慢性病盛行率不斷上升，這推動了中國市場的成長。

公司簡介

亞太地區輸液設備市場的主要參與者包括B Braun SE、百特國際公司 (Baxter International Inc)、Becton Dickinson and Co、BPL Medical Technologies Pvt Ltd、CODAN US Corp、Eitan Medical Ltd、Elimedical Inc、Fresenius Kabi AG、ICU Medical Technologies Inc、KD Scientific Inc、美敦力公司 (prodic Plc Inc. Corp)、Polymedicure、Tandem Diabetes Care Inc、泰爾茂公司 (Terumo Corp) 和 Zimed Healthcare Ltd 等。這些公司正在積極推行市場擴張、產品創新和併購等策略，以提升市場佔有率並為消費者提供創新解決方案。

目錄

第1章：簡介

第2章：執行摘要

  • 關鍵見解

第3章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：

第4章：亞太輸液設備市場格局

  • PEST分析

第5章：亞太輸液設備市場－主要市場動態

  • 亞太輸液設備市場－主要市場動態
  • 市場促進因素
    • 癌症發生率不斷上升
    • 老年人口不斷增加
  • 市場限制
    • 輸液設備頻繁召回
  • 市場機會
    • 市場參與者的策略性舉措
  • 未來趨勢
    • 不斷進步的技術
  • 促進因素和限制因素的影響：

第6章：亞太輸液設備市場 - 分析

  • 2021-2031年亞太地區輸液設備市場收入
  • 亞太輸液設備市場預測分析

第7章：亞太輸液設備市場分析－依產品類型

  • 點滴幫浦
  • 點滴器

第8章：亞太輸液設備市場分析－依應用

  • 糖尿病
  • 腫瘤學
  • 疼痛管理
  • 血液學
  • 兒科
  • 胃腸病學
  • 其他

第9章：亞太輸液設備市場分析－按最終用戶

  • 醫院和專科診所
  • 家庭護理設置
  • 門診手術中心
  • 其他

第 10 章：亞太輸液設備市場 - 國家分析

  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區

第 11 章：產業格局

  • 概述
  • 輸液設備市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第12章：公司簡介

  • Becton Dickinson and Co
  • Fresenius Kabi AG
  • B Braun SE
  • CODAN US Corp
  • Baxter International Inc
  • Elimedical Inc
  • ICU Medical Inc
  • BPL Medical Technologies Pvt Ltd
  • Nipro Corp
  • KD Scientific Inc
  • Medtronic Plc
  • Zimed Healthcare Ltd
  • Terumo Corp
  • Eitan Medical Ltd
  • Polymedicure
  • Moog Inc
  • Tandem Diabetes Care Inc

第 13 章：附錄

Product Code: BMIRE00032020

The Asia Pacific infusion devices market is projected to grow significantly, reaching approximately US$ 5,490.48 million by 2031, up from US$ 3,014.20 million in 2023, reflecting a compound annual growth rate (CAGR) of 7.8% during the forecast period from 2023 to 2031.

Executive Summary and Market Analysis

The Asia Pacific region, which includes countries such as China, Japan, India, Australia, South Korea, and others, is experiencing rapid growth in the infusion devices market. This growth is driven by several factors, including the increasing number of market players introducing innovative and cost-effective products, supportive initiatives from local governments, and a rising incidence of chronic diseases like cancer and diabetes. The presence of local manufacturers also enhances the accessibility of infusion devices across the region.

Market Segmentation

The Asia Pacific infusion devices market can be segmented based on product type, application, and end user.

1. Product Type: The market is divided into infusion pumps and infusion sets. In 2023, infusion pumps dominated the market share. Within infusion pumps, the segments include volumetric pumps, syringe pumps, insulin pumps, patient-controlled analgesia (PCA) pumps, enteral pumps, implantable pumps, and elastomeric pumps, with volumetric pumps holding the largest share. Infusion sets are categorized into vented and non-vented sets, with vented sets leading in market share.

2. Application: The market is further segmented by application into diabetes, oncology, pain management, hematology, pediatrics, gastroenterology, and others. Diabetes applications accounted for the largest market share in 2023.

3. End User: The end users of infusion devices include hospitals and specialty clinics, homecare settings, ambulatory surgical centers, and others, with hospitals and specialty clinics representing the largest segment in 2023.

Market Outlook

Key players in the Asia Pacific infusion devices market are focusing on strategic initiatives such as product launches, mergers, acquisitions, and collaborations to enhance their offerings for chronic conditions like diabetes, cancer, and chronic pain. Recent developments include:

  • In February 2023, Mindray introduced the BeneFusion i Series and u Series infusion systems, designed for high precision and safety in medication delivery across various clinical environments.
  • In March 2022, Fresenius Kabi received FDA clearance for its Agilia Connect Infusion System, which includes advanced volumetric and syringe pumps equipped with Vigilant Software Suite technology.
  • Eitan Medical launched operations in the UK in January 2021 to better support its Sapphire infusion pump customers, including NHS Trusts and private healthcare providers.

These advancements indicate a growing trend of product approvals and strategic partnerships, which are expected to create significant opportunities in the infusion devices market.

Country Insights

The Asia Pacific infusion devices market is notably influenced by country-specific dynamics. China emerged as the largest market in 2023. For instance, in October 2021, EOFlow Co., Ltd. established a joint venture with Changsha Sinocare Co., Ltd. to penetrate the expanding Chinese diabetes market, focusing on the production and distribution of the EOPatch, a wearable insulin pump. Additionally, China imported over 2 million infusion pumps valued at US$ 0.235 million in 2023, ranking second among the top importers of infusion pumps. The increasing prevalence of chronic diseases necessitating infusion therapies is propelling market growth in China.

Company Profiles

Key players in the Asia Pacific infusion devices market include B Braun SE, Baxter International Inc, Becton Dickinson and Co, BPL Medical Technologies Pvt Ltd, CODAN US Corp, Eitan Medical Ltd, Elimedical Inc, Fresenius Kabi AG, ICU Medical Inc, KD Scientific Inc, Medtronic Plc, Moog Inc, Nipro Corp, Polymedicure, Tandem Diabetes Care Inc, Terumo Corp, and Zimed Healthcare Ltd, among others. These companies are actively pursuing strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their market presence and deliver innovative solutions to consumers.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Asia Pacific Infusion Devices Market Landscape

  • 4.1 PEST Analysis

5. Asia Pacific Infusion Devices Market - Key Market Dynamics

  • 5.1 Asia Pacific Infusion Devices Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increasing Prevalence of Cancer
    • 5.2.2 Growing Geriatric Population
  • 5.3 Market Restraints
    • 5.3.1 Frequent Product Recalls of Infusion Devices
  • 5.4 Market Opportunities
    • 5.4.1 Strategic Initiatives by Market Players
  • 5.5 Future Trends
    • 5.5.1 Growing Technological Advancements
  • 5.6 Impact of Drivers and Restraints:

6. Asia Pacific Infusion Devices Market - Analysis

  • 6.1 Asia Pacific Infusion Devices Market Revenue (US$ Million), 2021-2031
  • 6.2 Asia Pacific Infusion Devices Market Forecast Analysis

7. Asia Pacific Infusion Devices Market Analysis - by Product Type

  • 7.1 Infusion Pumps
    • 7.1.1 Overview
    • 7.1.2 Infusion Pumps: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Infusion Sets
    • 7.2.1 Overview
    • 7.2.2 Infusion Sets: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Asia Pacific Infusion Devices Market Analysis - by Application

  • 8.1 Diabetes
    • 8.1.1 Overview
    • 8.1.2 Diabetes: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Oncology
    • 8.2.1 Overview
    • 8.2.2 Oncology: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.3 Pain Management
    • 8.3.1 Overview
    • 8.3.2 Pain Management: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.4 Hematology
    • 8.4.1 Overview
    • 8.4.2 Hematology: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.5 Pediatrics
    • 8.5.1 Overview
    • 8.5.2 Pediatrics: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.6 Gastroenterology
    • 8.6.1 Overview
    • 8.6.2 Gastroenterology: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Asia Pacific Infusion Devices Market Analysis - by End User

  • 9.1 Hospitals and Specialty Clinics
    • 9.1.1 Overview
    • 9.1.2 Hospitals and Specialty Clinics: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.2 Homecare Settings
    • 9.2.1 Overview
    • 9.2.2 Homecare Settings: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.3 Ambulatory Surgical Centers
    • 9.3.1 Overview
    • 9.3.2 Ambulatory Surgical Centers: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.4 Others
    • 9.4.1 Overview
    • 9.4.2 Others: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Asia Pacific Infusion Devices Market - Country Analysis

  • 10.1 Asia Pacific
    • 10.1.1 Asia Pacific Infusion Devices Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 Asia Pacific Infusion Devices Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.2 China: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.2.1 China: Asia Pacific Infusion Devices Market Share - by Product Type
        • 10.1.1.2.2 China: Asia Pacific Infusion Devices Market Share - by Infusion Pumps
        • 10.1.1.2.3 China: Asia Pacific Infusion Devices Market Share - by Infusion Sets
        • 10.1.1.2.4 China: Asia Pacific Infusion Devices Market Share - by Application
        • 10.1.1.2.5 China: Asia Pacific Infusion Devices Market Share - by End User
      • 10.1.1.3 Japan: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.3.1 Japan: Asia Pacific Infusion Devices Market Share - by Product Type
        • 10.1.1.3.2 Japan: Asia Pacific Infusion Devices Market Share - by Infusion Pumps
        • 10.1.1.3.3 Japan: Asia Pacific Infusion Devices Market Share - by Infusion Sets
        • 10.1.1.3.4 Japan: Asia Pacific Infusion Devices Market Share - by Application
        • 10.1.1.3.5 Japan: Asia Pacific Infusion Devices Market Share - by End User
      • 10.1.1.4 India: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.4.1 India: Asia Pacific Infusion Devices Market Share - by Product Type
        • 10.1.1.4.2 India: Asia Pacific Infusion Devices Market Share - by Infusion Pumps
        • 10.1.1.4.3 India: Asia Pacific Infusion Devices Market Share - by Infusion Sets
        • 10.1.1.4.4 India: Asia Pacific Infusion Devices Market Share - by Application
        • 10.1.1.4.5 India: Asia Pacific Infusion Devices Market Share - by End User
      • 10.1.1.5 Australia: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.5.1 Australia: Asia Pacific Infusion Devices Market Share - by Product Type
        • 10.1.1.5.2 Australia: Asia Pacific Infusion Devices Market Share - by Infusion Pumps
        • 10.1.1.5.3 Australia: Asia Pacific Infusion Devices Market Share - by Infusion Sets
        • 10.1.1.5.4 Australia: Asia Pacific Infusion Devices Market Share - by Application
        • 10.1.1.5.5 Australia: Asia Pacific Infusion Devices Market Share - by End User
      • 10.1.1.6 South Korea: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.6.1 South Korea: Asia Pacific Infusion Devices Market Share - by Product Type
        • 10.1.1.6.2 South Korea: Asia Pacific Infusion Devices Market Share - by Infusion Pumps
        • 10.1.1.6.3 South Korea: Asia Pacific Infusion Devices Market Share - by Infusion Sets
        • 10.1.1.6.4 South Korea: Asia Pacific Infusion Devices Market Share - by Application
        • 10.1.1.6.5 South Korea: Asia Pacific Infusion Devices Market Share - by End User
      • 10.1.1.7 Rest of APAC: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.7.1 Rest of APAC: Asia Pacific Infusion Devices Market Share - by Product Type
        • 10.1.1.7.2 Rest of APAC: Asia Pacific Infusion Devices Market Share - by Infusion Pumps
        • 10.1.1.7.3 Rest of APAC: Asia Pacific Infusion Devices Market Share - by Infusion Sets
        • 10.1.1.7.4 Rest of APAC: Asia Pacific Infusion Devices Market Share - by Application
        • 10.1.1.7.5 Rest of APAC: Asia Pacific Infusion Devices Market Share - by End User

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Infusion Devices Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Becton Dickinson and Co
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Fresenius Kabi AG
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 B Braun SE
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 CODAN US Corp
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Baxter International Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Elimedical Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 ICU Medical Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 BPL Medical Technologies Pvt Ltd
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Nipro Corp
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 KD Scientific Inc
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Medtronic Plc
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments
  • 12.12 Zimed Healthcare Ltd
    • 12.12.1 Key Facts
    • 12.12.2 Business Description
    • 12.12.3 Products and Services
    • 12.12.4 Financial Overview
    • 12.12.5 SWOT Analysis
    • 12.12.6 Key Developments
  • 12.13 Terumo Corp
    • 12.13.1 Key Facts
    • 12.13.2 Business Description
    • 12.13.3 Products and Services
    • 12.13.4 Financial Overview
    • 12.13.5 SWOT Analysis
    • 12.13.6 Key Developments
  • 12.14 Eitan Medical Ltd
    • 12.14.1 Key Facts
    • 12.14.2 Business Description
    • 12.14.3 Products and Services
    • 12.14.4 Financial Overview
    • 12.14.5 SWOT Analysis
    • 12.14.6 Key Developments
  • 12.15 Polymedicure
    • 12.15.1 Key Facts
    • 12.15.2 Business Description
    • 12.15.3 Financial Overview
    • 12.15.4 SWOT Analysis
    • 12.15.5 Key Developments
  • 12.16 Moog Inc
    • 12.16.1 Key Facts
    • 12.16.2 Business Description
    • 12.16.3 Products and Services
    • 12.16.4 Financial Overview
    • 12.16.5 SWOT Analysis
    • 12.16.6 Key Developments
  • 12.17 Tandem Diabetes Care Inc
    • 12.17.1 Key Facts
    • 12.17.2 Business Description
    • 12.17.3 Products and Services
    • 12.17.4 Financial Overview
    • 12.17.5 SWOT Analysis
    • 12.17.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners

List Of Tables

  • Table 1. Asia Pacific Infusion Devices Market Segmentation
  • Table 2. Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Product Type
  • Table 4. Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
  • Table 5. Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million) - by End User
  • Table 6. Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 7. China: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
  • Table 8. China: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infusion Pumps
  • Table 9. China: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infusion Sets
  • Table 10. China: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 11. China: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 12. Japan: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
  • Table 13. Japan: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infusion Pumps
  • Table 14. Japan: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infusion Sets
  • Table 15. Japan: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 16. Japan: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 17. India: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
  • Table 18. India: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infusion Pumps
  • Table 19. India: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infusion Sets
  • Table 20. India: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 21. India: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 22. Australia: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
  • Table 23. Australia: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infusion Pumps
  • Table 24. Australia: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infusion Sets
  • Table 25. Australia: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 26. Australia: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 27. South Korea: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
  • Table 28. South Korea: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infusion Pumps
  • Table 29. South Korea: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infusion Sets
  • Table 30. South Korea: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 31. South Korea: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 32. Rest of APAC: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
  • Table 33. Rest of APAC: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infusion Pumps
  • Table 34. Rest of APAC: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infusion Sets
  • Table 35. Rest of APAC: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 36. Rest of APAC: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 37. Recent Organic Growth Strategies in Infusion Devices Market
  • Table 38. Recent Inorganic Growth Strategies in the Infusion Devices Market

List Of Figures

  • Figure 1. Asia Pacific Infusion Devices Market Segmentation - Country
  • Figure 2. PEST Analysis
  • Figure 1. Global Incidence of Cancer, 2022
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. Asia Pacific Infusion Devices Market Revenue (US$ Million), 2021-2031
  • Figure 4. Asia Pacific Infusion Devices Market Share (%) - by Product Type (2023 and 2031)
  • Figure 5. Infusion Pumps: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 6. Infusion Sets: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 7. Asia Pacific Infusion Devices Market Share (%) - by Application (2023 and 2031)
  • Figure 8. Diabetes: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Oncology: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Pain Management: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. Hematology: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 12. Pediatrics: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Gastroenterology: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Others: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 15. Asia Pacific Infusion Devices Market Share (%) - by End User (2023 and 2031)
  • Figure 16. Hospitals and Specialty Clinics: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 17. Homecare Settings: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 18. Ambulatory Surgical Centers: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. Others: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 20. Asia Pacific Infusion Devices Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 21. China: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 22. Japan: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 23. India: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 24. Australia: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 25. South Korea: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 26. Rest of APAC: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 27. Growth Strategies in Infusion Devices Market